12273-9 |
Xanthochromia |
PrThr |
Body fld |
Pt |
Ord |
|
|
ACTIVE |
Xanthochromia [Presence] of Body fluid Qualitative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
12273-9 |
|
|
|
|
Observation |
|
|
|
0 |
Xanthochromia Fld Ql |
|
|
|
|
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SPEC; Xanthchromia; Xanthochromic |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12274-7 |
Xylose |
MRat |
Urine |
5H |
Qn |
|
|
ACTIVE |
Xylose [Mass/time] in 5 hour Urine |
|
MIN |
DefinitionDescription |
|
|
g/5 H |
|
|
|
|
|
|
CHEM |
|
12274-7 |
|
|
|
|
Both |
|
|
|
0 |
Xylose 5h Ur-mRate |
|
|
|
Y |
|
5 hours; 5.0Hr; 5HR; Chemistry; D-xylose; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.7 |
1.0j-a |
|
|
|
|
|
|
|
g/(5.h) |
|
|
|
0 |
12275-4 |
Yeast |
PrThr |
Genital |
Pt |
Ord |
Wet preparation |
|
ACTIVE |
Yeast [Presence] in Genital specimen by Wet preparation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
12275-4 |
|
Wet preparation |
|
|
Both |
|
|
|
0 |
Yeast Genital Ql Wet Prep |
|
|
|
|
|
Gen; Genital tract; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Prep; QL; Qual; Qualitative; Random; Screen; Urogenit; Urogenital; Wet mount; Wet prep |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12276-2 |
Escherichia coli O157:H7 |
ACnc |
Stool |
Pt |
Ord |
Organism specific culture |
|
DEPRECATED |
Deprecated Escherichia coli O157:H7 identified in Stool by Organism specific culture |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
12276-2 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Deprecated E coli O157H7 Stl Cult |
|
|
|
|
|
Arbitrary concentration; Bowel movement; C&S; Cult; Cultures; E coli; E coli O157; E coli O157H7; Enterohemorrhagic E. coli; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; Microbiology; o002; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; Stl; Stool = Fecal |
2.36 |
1.0j-a |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
12277-0 |
DNA double strand Ab |
PrThr |
Ser |
Pt |
Ord |
Farr |
|
ACTIVE |
DNA double strand Ab [Presence] in Serum by Farr method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
12277-0 |
|
Farr |
|
|
Both |
|
|
|
0 |
dsDNA Ab Ser Ql Farr |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; Native DNA; N-DNA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Stranded; Strnd |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12278-8 |
Neutrophils.band form/Leukocytes |
NFr |
CSF |
Pt |
Qn |
Manual count |
|
ACTIVE |
Band form neutrophils/Leukocytes in Cerebral spinal fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
12278-8 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Neuts Band NFr CSF Manual |
|
|
|
Y |
|
Bands; bnd; Cerebral spinal fluid; Cerebrospinal Fl; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number Fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WBC; WBCs; White blood cell; White blood cells |
2.79 |
1.0j-a |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
12279-6 |
Spermatozoa Ab |
ACnc |
Semen |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Spermatozoa Ab [Units/volume] in Semen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
FERT |
|
12279-6 |
|
|
|
|
|
|
|
|
0 |
Deprecated Sperm Ab Smn-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Ejaculate; FERTILITY TESTING; Genitourinary; GU; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; URO; Urology |
2.69 |
1.0j-a |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
1228-6 |
M Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
M Ab [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1228-6 |
|
|
|
|
Observation |
|
|
|
0 |
M Ab SerPl Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; MNSs Blood Group System; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12280-4 |
Alanine |
MCnc |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Alanine [Mass/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
12280-4 |
|
|
|
|
Observation |
|
|
|
0 |
Alanine Amn-mCnc |
|
|
|
Y |
|
AF; Ala; Alpha alanine; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; L-alanine; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.34 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
12281-2 |
Bacteria |
Prid |
Cvx |
Pt |
Nom |
Anaerobic culture |
|
ACTIVE |
Bacteria identified in Cervix by Anaerobe culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
12281-2 |
|
Anaerobic culture |
|
|
Both |
|
|
|
0 |
Bacteria Cvx Anaerobe Cult |
|
|
|
|
|
Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cervix; Cult; Cultures; Genital tract; Gyn; Gynecology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random |
2.78 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
12282-0 |
Warfarin |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Warfarin [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12282-0 |
|
|
|
|
Both |
|
|
|
0 |
Warfarin Ur Ql |
|
|
|
|
|
4-Hydroxycoumarin; Coumadin; Coumarin; Coumarins; DRUG/TOXICOLOGY; Drugs; Ordinal; Panwarfin; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sofarin; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12283-8 |
Corticotropin releasing hormone |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Corticotropin releasing hormone [Units/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
12283-8 |
|
|
|
|
Both |
|
|
|
0 |
ACTH RH SerPl-aCnc |
|
|
|
Y |
|
ACTH; ACTH RH; Adrenocorticotrophic hormone; Adrenocorticotropin; Arbitrary concentration; c206; c74; Chemistry; Corticotropin Releasing Factor; Cortrosyn; CRF; CRH; Horm; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker |
2.69 |
1.0j-a |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
12284-6 |
Growth hormone-releasing hormone |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Growth hormone-releasing hormone [Units/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
12284-6 |
|
|
|
|
Both |
|
|
|
0 |
GHRH SerPl-aCnc |
|
|
|
Y |
|
Arbitrary concentration; Chemistry; GHRF; GHRH; Growth hormone-releasing factor; Horm; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatocrinin; Somatoliberin; Somatropin releasing hormone; SR; SRH |
2.69 |
1.0j-a |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
12285-3 |
HLA-DP |
Type |
Bld/Tiss |
Pt |
Nom |
|
|
ACTIVE |
HLA-DP [Type] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
12285-3 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DP |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types. |
0 |
12286-1 |
Drugs |
Prid |
Urine |
Pt |
Nom |
Screen |
|
ACTIVE |
Drugs identified in Urine by Screen method Nominal |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12286-1 |
|
Screen |
|
|
Both |
|
|
|
0 |
Drugs Ur Scn Nom |
|
|
|
|
|
Drug; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.79 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
12287-9 |
Drugs |
Prid |
Gast fld |
Pt |
Nom |
Screen |
|
ACTIVE |
Drugs identified in Gastric fluid by Screen method |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12287-9 |
|
Screen |
|
|
Both |
|
|
|
0 |
Drugs Gast Scn |
|
|
|
|
|
Drug; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Identity or presence; Nominal; Point in time; Random; Scn; Scr; Scrn |
2.79 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
12288-7 |
Diuretics |
Prid |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Diuretics [Identifier] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12288-7 |
|
|
|
|
Both |
|
|
|
0 |
Diuretics Ur |
|
|
|
|
|
diuretic; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
12289-5 |
Drugs |
Prid |
Vitr fld |
Pt |
Nom |
Screen |
|
ACTIVE |
Drugs identified in Vitreous fluid by Screen method |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12289-5 |
|
Screen |
|
|
Both |
|
|
|
0 |
Drugs Vitf Scn |
|
|
|
|
|
Drug; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; Scn; Scr; Scrn; VitF; Vitreous Fluid; Vitreous humor; Vitreous humour |
2.79 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
1229-4 |
M Ag |
PrThr |
RBC^BPU |
Pt |
Ord |
|
|
ACTIVE |
M Ag [Presence] on Red Blood Cells from Blood product unit |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1229-4 |
|
|
|
|
Observation |
|
|
|
0 |
M Ag RBC BPU Ql |
|
|
|
|
|
Antigen; Antigens; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Erythrocytes; Hematology; Heme; MNSs Blood Group System; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12290-3 |
Procyclidine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Procyclidine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12290-3 |
|
|
|
|
Both |
|
|
|
0 |
Procyclidine Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Kemadrin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12291-1 |
Mephentermine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Mephentermine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12291-1 |
|
|
|
|
Both |
|
|
|
0 |
Mephentermine Ur Ql |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Phentermine metabolite; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12292-9 |
Dimethyltryptamine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Dimethyltryptamine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12292-9 |
|
|
|
|
Both |
|
|
|
0 |
Dimet-tryptamine Ur Ql |
|
|
|
|
|
Dimet-tryptamine; DMT; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12293-7 |
Cotinine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Cotinine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12293-7 |
|
|
|
|
Both |
|
|
|
0 |
Cotinine Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Nicotine metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UniversalLabOrders; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12294-5 |
Nicotine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Nicotine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12294-5 |
|
|
|
|
Both |
|
|
|
0 |
Nicotine Ur Ql |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Habitrol; Illicit; Nicoderm; Nictoine; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
12295-2 |
Hallucinogens |
Prid |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Hallucinogens [Identifier] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12295-2 |
|
|
|
|
Both |
|
|
|
0 |
Hallucinogens Ur |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; UA; UR; Urn |
2.19 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |